skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: THE PHARMACOLOGY OF RADIOPROTECTANT CHEMICALS. GENERAL PHARMACOLOGY OF / cap beta/-MERCAPTOETHYLAMINE

Journal Article · · Radiation Research
DOI:https://doi.org/10.2307/3570928· OSTI ID:4145863

When 100 mg of beta -mercaptoethylamine is administered intravenously to the dog over a period of 5 min a characteristic set of reactions is produced. The most notable of these in the nonanesthetized dog are violent emesis, agitation frequently leading to tonic-clonic convulsions, ataxia and a characteristic swaying movement of the front portion of the body, generalized depression, loss of pain sense, severe hypotension, relative bradycardia, blood- tinged diarrhea, and a mixed stimulation and depression of respiration. Anesthesia prevents the emetic and convulsive components of the reaction but does not affect the cardiovascular changes. The agent produces a delayed, severe, prolonged hypotension. The possibility is discussed that the physiological changes produced by this agent may contribute to its radioprotective potential. 27 references. (auth)

Research Organization:
Walter Reed Army Medical Center, Washington, D.C.
Sponsoring Organization:
USDOE
NSA Number:
NSA-14-023865
OSTI ID:
4145863
Journal Information:
Radiation Research, Vol. Vol: 13; Other Information: Orig. Receipt Date: 31-DEC-60
Country of Publication:
Country unknown/Code not available
Language:
English